Owen B. Wallace's Net Worth
$1.17 Million
Who is Owen B. Wallace?
Owen B. Wallace has an estimated net worth of $1.17 Million. This is based on reported shares across multiple companies, which include Fulcrum Therapeutics, Inc., and Monte Rosa Therapeutics, Inc..
SEC CIK
Owen B. Wallace's CIK is 0001778843
Past Insider Trading and Trends
2020 was Owen B. Wallace's most active year for acquiring shares with 8 total transactions. Owen B. Wallace's most active month to acquire stocks was the month of April. 2020 was Owen B. Wallace's most active year for disposing of shares, totalling 13 transactions. Owen B. Wallace's most active month to dispose stocks was the month of April. 2020 saw Owen B. Wallace paying a total of $145,996.48 for 77,522 shares, this is the most they've acquired in one year. In 2020 Owen B. Wallace cashed out on 30,894 shares for a total of $245,440.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Fulcrum Therapeutics, Inc. (FULC) Snapshot price: $7.9902
Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +5.00% | 6.35K |
$7.84 | $49,784.00 | 133.44K |
Sep 14
| |||
Form 4
|
—
|
0
|
$13.92 | -$35,884.16 | 127.09K |
Scheduled
|
Jul 8
| ||
Form 4
|
—
|
0
|
$13.92 | -$1,714.56 | 127.09K |
Scheduled
|
Jun 30
| ||
Form 4
|
—
|
0
|
$13.92 | -$27,141.12 | 127.09K |
Scheduled
|
May 28
| ||
Form 4
|
—
|
0
|
$13.92 | -$5,447.68 | 127.09K |
Scheduled
|
May 27
| ||
Form 4
|
—
|
0
|
$13.92 | -$5,009.92 | 127.09K |
Scheduled
|
May 26
| ||
Form 4
|
—
|
0
|
$13.92 | -$74,030.08 | 127.09K |
Scheduled
|
Feb 19
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Monte Rosa Therapeutics, Inc. (GLUE) Snapshot price: $4.715
Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 12 - Jun 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||